Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
For the quarter ended June 30, 2026, Sumitomo Chemical India reported a 1% year-over-year increase in revenue to ₹1,063 crore. Exports showed significant growth, rising by 26%. Gross profit increased by 4% to ₹985.5 crore, and EBITDA grew by 6% to ₹233 crore. Net profit reached ₹215 crore, aided by a ₹26.9 crore insurance claim related to a prior year fire incident.
Effective September 1, 2026, Dr. Suresh Ramachandran was re-appointed and promoted to Managing Director. Mr. N. Sivaraman was reappointed as an Independent Director for three years, and Mr. Anand Mohan Tiwari was appointed as an Independent Director for two years. Mr. Chetan Shah transitioned from Managing Director to Non-Executive Non-Independent Director. Additionally, Mr. Ninad D. Gupte resigned as a Non-Executive, Non-Independent Director effective August 31, 2026.
At the Annual General Meeting held on July 27, 2026, Sumitomo Chemical India declared a dividend of ₹1.30 per share for the year ended March 31, 2026.
As of September 17, 2026, the daily technical trend for Sumitomo Chemical India indicates a bearish SuperTrend direction with the SuperTrend indicator at ₹499.01. The 14-day ADX is 32.31, suggesting a strong trend. However, the weekly trend shows a bullish SuperTrend direction at ₹424.89, with a 14-day ADX of 26.05, indicating a less defined trend on the weekly timeframe.
As of 18 Sept 2026, 03:30 pm
Showing 3 of 14 candles
Recent drawdown or price variability is high enough to warrant closer monitoring.
Primary driver: Price remains materially below a previous peak
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
The session traded across a materially wider price range than usual.
Larger price swings can increase short-term uncertainty, especially if they continue.
Trading volume was unusually high, but the closing price did not show a clear directional move.
This indicates increased participation without a clear directional signal.
The session opened materially above the previous close, indicating a sharp repricing at the open.
The move may reflect new information; subsequent price follow-through is worth monitoring.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Profit Before Tax | PEAK₹288.24 crore | ₹147.55 crore | ₹101.57 crore | ₹237.85 crore | ₹240.59 crore |
| Profit Before Exceptional Items And Tax | PEAK₹261.35 crore | ₹147.52 crore | ₹117.69 crore | ₹237.85 crore | ₹240.59 crore |
| Exceptional Items Before Tax | PEAK₹26.90 crore | ₹3.50 lakh | -₹16.11 crore | ₹0.0 | ₹0.0 |
| Revenue From Operations | PEAK₹1,063.35 crore | ₹683.74 crore | ₹567.98 crore | ₹929.82 crore | ₹1,056.78 crore |
| Profit Loss For Period | PEAK₹214.51 crore | ₹111.32 crore | ₹75.80 crore | ₹177.76 crore | ₹178.10 crore |
| Basic Earnings Loss Per Share From Continuing And Discontinued Operations | PEAK₹4.30 per share | ₹2.23 per share | ₹1.52 per share | ₹3.56 per share | ₹3.57 per share |
Revenue from operations was ₹1,063.35 crore, a marginal 0.6% increase from ₹1,056.78 crore in Q1 FY2025-26. In the previous fiscal year, Q1 was the highest revenue quarter, and the current quarter continues that pattern, with revenue significantly above the ₹683.74 crore recorded in Q4 FY2025-26.
The quarter included an exceptional income before tax of ₹26.90 crore, compared to nil in Q1 FY2025-26. In the preceding four quarters, exceptional items were either negative (a loss of ₹16.11 crore in Q3 FY2025-26) or negligible. This gain contributed substantially to the reported PBT growth and is a non-recurring element. Note: The exceptional item amount is subject to final confirmation.
Basic earnings per share was ₹4.30, up from ₹3.57 in Q1 FY2025-26, in line with net profit growth. The implied weighted average share count remained stable at approximately 49.9 crore shares, indicating no significant dilution or buyback activity.
Sumitomo Chemical India delivered a quarter of flat revenue but notably higher profit. The improvement came from both a higher pre-exceptional profit margin and a substantial exceptional gain. The exceptional item is non-recurring and subject to final confirmation. The seasonal revenue pattern, with Q1 as the strongest quarter, remained intact.
Exchange disclosures and regulatory announcements for Sumitomo Chemical India.
Sumitomo Chemical India Ltd. announced on August 25, 2026, that its officials will hold one-on-one and group meetings with investors and analysts organized by Elara Capital in Mumbai on September 3, 2026, starting at 9:00 A.M. The company confirmed that discussions will be restricted to publicly available information with no Unpublished Price Sensitive Information (UPSI) intended for disclosure.
Sumitomo Chemical India Ltd. informed stock exchanges on August 10, 2026, that its officials will hold a group meeting with investors/analysts on August 19, 2026, at 3:00 PM, organized by Motilal Oswal Financial Services Ltd. in Mumbai. The company stated discussions will be based on publicly available information and no unpublished price-sensitive information is intended to be shared.
Sumitomo Chemical India Ltd. held its Annual General Meeting on July 27, 2026, where resolutions were passed including the adoption of financial statements for the year ended March 31, 2026, and a dividend declaration of ₹1.30 per share. Key appointments and reappointments were approved: Dr. Suresh Ramachandran was re-appointed and promoted to Managing Director effective September 1, 2026; Mr. N. Sivaraman was reappointed as an Independent Director from September 1, 2026, for three years; and Mr. Anand Mohan Tiwari was appointed as an Independent Director from August 31, 2026, for two years. Mr. Chetan Shah transitioned from Managing Director to Non-Executive Non-Independent Director from September 1, 2026, with approved fees for one year. Approval was also given for material related party transactions with Sumitomo Chemical Company, Limited for FY 2026-27 and ratification of cost auditor remuneration.
Sumitomo Chemical India Limited has released its investor presentation for the quarter ended June 30, 2026. The company reported a 1% year-over-year revenue increase to Rs. 1,063 crore, with exports growing by 26%. Gross profit rose 4% to Rs. 985.5 crore, and EBITDA increased 6% to Rs. 233 crore. Net profit reached Rs. 215 crore, boosted by a Rs. 26.9 crore insurance claim related to a prior year fire incident. The company also announced board member changes effective September 1, 2026, including the appointment of Dr. Suresh Ramachandran as Managing Director.
Mr. Ninad D. Gupte has resigned as a Non-Executive, Non-Independent Director of Sumitomo Chemical India Ltd. effective August 31, 2026, for personal reasons. He also holds directorships at Excel Industries Limited, where he chairs the Nomination & Remuneration Committee and is a member of the Audit and Risk Management Committees.
The 26th Annual General Meeting of Sumitomo Chemical India Limited was held on July 27, 2026, via video conferencing. Key agenda items included the adoption of audited financial statements for the year ended March 31, 2026, declaration of a dividend of ₹1.30 per equity share, and re-appointment of Dr. Suresh Ramachandran. Special business involved the re-appointment of Mr. N. Sivaraman and Mr. Anand Mohan Tiwari as Independent Directors, and the appointment of Mr. Chetan Shah as a Non-Executive Non-Independent Director. Dr. Suresh Ramachandran was promoted to Managing Director effective September 1, 2026. The meeting also addressed advisory fees for Mr. Chetan Shah, material related party transactions with Sumitomo Chemical Company, Limited, and ratification of remuneration for Cost Auditors.
Sumitomo Chemical India Ltd. reported its unaudited financial results for the quarter ended June 30, 2026, on July 27, 2026. The company's standalone revenue from operations was ₹10,540.75 million, with a profit after tax of ₹2,165.29 million. Consolidated revenue from operations was ₹10,633.46 million, with a profit after tax of ₹2,145.14 million. The company also disclosed receiving an insurance claim of ₹268.96 million for business interruption due to a fire incident at its Bhavnagar plant.
Sumitomo Chemical India Ltd. announced its unaudited financial results for the quarter ended June 30, 2026, on July 27, 2026. The company reported revenue from operations of ₹10,540.75 million for the standalone quarter and ₹10,633.46 million for the consolidated quarter. The Board of Directors approved these results, which were reviewed by the Audit Committee. The company also noted an insurance claim of ₹268.96 million received for business interruption due to a fire incident at the Bhavnagar plant.
Recent market and company developments associated with Sumitomo Chemical India.
The second day of SEMICON India 2026 saw 25 announcements and collaborations across semiconductor manufacturing, materials, logistics, chip design, advanced packaging, power electronics and workforce development, as Indian and global companies expanded partnerships across the semiconductor value chain.
Tata Electronics, Tata Electronics semiconductor, Tata Electronics semiconductor partnerships, Tata Electronics Dholera fab, Dholera semiconductor fab, Tata Electronics Gujarat, Tata Electronics Assam, Tata Electronics Jagiroad, semiconductor manufacturing India, semiconductor ecosystem India, India semiconductor industry, Tata semiconductor plant
MarketSmith India reveals its top stock recommendations for today, 19 August. Get expert insights into the best-performing stocks to guide your investment decisions.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks to buy today — SJS Enterprises, Honasa Consumer, Suven Life Sciences, Sumitomo Chemical India, and Asahi India Glass.
Market expert Raja Venkatraman shares his top stock picks for 17 August. Here’s his technical outlook and trade strategy.
Sumitomo Chemical India Q1 FY27 standalone net profit rose 20.4 percent YoY to Rs 216.5 crore, while revenue from operations increased marginally to Rs 1,054 crore, aided by an insurance claim.
Comprehensive Section Breakdown for Sumitomo Chemical India
Strategic Vision: Manufactures and markets crop protection, environmental health, and animal nutrition products.
• Integrated product portfolio sourced from parent company and subsidiaries.
• Established distribution network for domestic and international markets.
• Focus on research and development for chemical and biological solutions.
Sumitomo Chemical India Limited reported nearly unchanged revenue for the first quarter of FY2026-27, but profit before tax rose sharply. The increase was driven by an improvement in underlying profitability and a significant exceptional gain. Even excluding the exceptional item, profit before tax grew 8.6% on flat revenue, reflecting a higher pre-exceptional profit margin.
Profit before tax (PBT) reached ₹288.24 crore, up 19.8% from ₹240.59 crore a year ago. Net profit rose 20.5% to ₹214.51 crore. These figures include an exceptional gain of ₹26.90 crore (subject to final confirmation). Other income for the quarter was ₹47.28 crore.
Excluding exceptional items, PBT was ₹261.35 crore, an 8.6% increase from ₹240.59 crore. The pre-exceptional PBT margin improved to 24.6% of revenue from 22.8% a year ago, indicating better profitability on a flat revenue base.
Major expense items for the quarter were:
Other expenses declined from ₹112.35 crore in Q1 last year, contributing to the improvement in profitability. Finance costs increased slightly from ₹1.66 crore a year ago.
Category: Manufacturing
This segment includes a range of chemical and organic products for crop protection and plant growth regulators.
Category: Manufacturing
The company provides products that address the dietary needs of animals.
Category: Manufacturing
This category encompasses products for environmental health, professional pest control, household pesticides, fumigants, and rodenticides.
Core Thesis: Different product segments reinforce each other through shared R&D and distribution channels.
• Product Sourcing and Innovation: Leverages R&D to innovate and deliver chemical and biological solutions, sourcing conventional products from its parent and biological products from a subsidiary. • Sales and Distribution Network: Emphasizes strengthening its sales force and distribution network to expand market penetration within India and for exports. • Manufacturing Expansion: Focuses on expanding its manufacturing functions to meet demand for its diverse product portfolio. • Digital Transformation: Aims to assist farmers in adopting digital practices in agriculture through digital transformation initiatives.